Ipca Laboratories Limited
Ipca Laboratories Limited lists 24 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 83980-024 | Atenolol Tablet | Atenolol 100 mg/1 | Rx |
| 83980-023 | Atenolol Tablet | Atenolol 50 mg/1 | Rx |
| 83980-022 | Atenolol Tablet | Atenolol 25 mg/1 | Rx |
| 83980-062 | Chlorthalidone Tablet | Chlorthalidone 50 mg/1 | Rx |
| 83980-061 | Chlorthalidone Tablet | Chlorthalidone 25 mg/1 | Rx |
| 83980-032 | etodolac Capsule | Etodolac 300 mg/1 | Rx |
| 83980-031 | etodolac Capsule | Etodolac 200 mg/1 | Rx |
| 83980-030 | etodolac Tablet | Etodolac 500 mg/1 | Rx |
| 83980-029 | etodolac Tablet | Etodolac 400 mg/1 | Rx |
| 83980-002 | Furosemide Tablet | Furosemide 20 mg/1 | Rx |
| 83980-004 | Furosemide Tablet | Furosemide 80 mg/1 | Rx |
| 83980-003 | Furosemide Tablet | Furosemide 40 mg/1 | Rx |
| 83980-001 | Hydroxychloroquine Sulfate Tablet, Film Coated | Hydroxychloroquine Sulfate 200 mg/1 | Rx |
| 83980-011 | Metoclopramide Tablet | Metoclopramide Hydrochloride 10 mg/1 | Rx |
| 83980-010 | Metoclopramide Tablet | Metoclopramide Hydrochloride 5 mg/1 | Rx |
| 83980-012 | Ondansetron Tablet, Orally Disintegrating | Ondansetron 4 mg/1 | Rx |
| 83980-013 | Ondansetron Tablet, Orally Disintegrating | Ondansetron 8 mg/1 | Rx |
| 83980-017 | ondansetron hydrochloride Tablet, Film Coated | Ondansetron Hydrochloride 4 mg/1 | Rx |
| 83980-018 | ondansetron hydrochloride Tablet, Film Coated | Ondansetron Hydrochloride 8 mg/1 | Rx |
| 83980-009 | Propranolol Hydrochloride Tablet | Propranolol Hydrochloride 80 mg/1 | Rx |
| 83980-008 | Propranolol Hydrochloride Tablet | Propranolol Hydrochloride 60 mg/1 | Rx |
| 83980-007 | Propranolol Hydrochloride Tablet | Propranolol Hydrochloride 40 mg/1 | Rx |
| 83980-006 | Propranolol Hydrochloride Tablet | Propranolol Hydrochloride 20 mg/1 | Rx |
| 83980-005 | Propranolol Hydrochloride Tablet | Propranolol Hydrochloride 10 mg/1 | Rx |